|
NYBA News |
Member News
|
Press Release
|
| |
|
|
News type
|
|
Amgen, Inc. |
|
Headline:
Amgen Launches 2007 Breakaway from Cancer Initiative
Date:
16-Jan-2007
News Type:
Member News
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Jan. 16, 2007--In an ongoing effort to raise
awareness of and funds to support free services and programs to help people affected by
cancer, Amgen (NASDAQ:AMGN) today announced one of TV's biggest stars - Patri ...
Details »
|
|
| |
|
ERBITUX® Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer |
|
Headline:
ERBITUX® Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
Date:
10-Jan-2007
News Type:
Member News
NEW YORK --(PRNewswire-FirstCall)-- Jan. 10, 2007 - ImClone S ...
Details »
|
|
| |
|
ZIOPHARM Oncology, Inc. |
|
Headline:
ZIOPHARM Initiates ZIO-101 Phase II Study in Hematological Cancers
Date:
09-Jan-2007
News Type:
Member News
NEW YORK --(BUSINESS WIRE)-- Jan. 9, 2007 - ZIOPHARM Oncology ...
Details »
|
|
| |
|
Acorda Therapeutics, Inc |
|
Headline:
Acorda Therapeutics Announces Completion of Zanaflex Capsules™ Sales Force Expansion
Date:
08-Jan-2007
News Type:
Member News
HAWTHORNE, N.Y. --(BUSINESS WIRE)-- Jan. 8, 2007 - Acorda The ...
Details »
|
|
| |
|
Progenics Pharmaceuticals, Inc. |
|
Headline:
Progenics Pharmaceuticals Expands Senior Management Team and Board of Directors
Date:
08-Jan-2007
News Type:
Member News
TARRYTOWN ...
Details »
|
|
| |
|
Genentech Inc. |
|
Headline:
Genentech Again Named One of FORTUNE's 100 Best Companies to Work For
Date:
08-Jan-2007
News Type:
Member News
SOUTH SAN FRANCISCO, Calif. --(PRNewswire-FirstCall)-- Jan. 8, 2007 ...
Details »
|
|
| |
|
OSI Pharmaceuticals Inc. |
|
Headline:
OSI Pharmaceuticals Licenses Its Glucokinase Activator Program for the Treatment of Type 2 Diabetes to Eli Lilly and Company
Date:
05-Jan-2007
News Type:
Member News
MELVILLE, N.Y. - (BUSINESS WIRE)--Jan. 5, 2007 - OSI Pharmace ...
Details »
|
|
| |
|
Genentech Inc. |
|
Headline:
Genentech Announces Positive Results from a Randomized Phase II Study of Pertuzumab in Combination with Gemcitabine for Advanced Ovarian Cancer
Date:
04-Jan-2007
News Type:
Member News
South San Francisco, Calif. - January 4, 2007 - Genentech, In ...
Details »
|
|
| |
|
ImClone Systems Commences Patient Treatment In U.S. Phase I Clinical Trial Of IMC-3G3 |
|
Headline:
ImClone Systems Commences Patient Treatment In U.S. Phase I Clinical Trial Of IMC-3G3
Date:
03-Jan-2007
News Type:
Member News
NEW YORK - (BUSINESS WIRE) - Jan. 3, 2007 - ImClone Systems I ...
Details »
|
|
| |
|
|
